Home › Parkinson's Disease › NCT03664609
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
RecruitingObservational study
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Must be previously treated with or eligible for implantation with a deep brain stimulation system Exclusion Criteria: * No Exclusion Criteria
About the study
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
What is being tested
- Deep Brain Stimulation (device)
Sponsor: Boston Scientific Corporation · Participants: 5,000 · Started: Mar 12, 2019
Contact the study team
- Cleo Mertz · Phone: 855-213-9890
- Diane Keesey · Phone: 855-213-9890
Official record on ClinicalTrials.gov — NCT03664609
Locations in the U.S.
| Arizona | St. Joseph's Hospital & Medical Center, Phoenix |
| California | Riverside University Health System, Moreno Valley University of California, San Francisco, San Francisco |
| Florida | University of Miami Hospital, Miami University of South Florida, Tampa |
| New York | Albany Medical Center, Albany |
| North Carolina | Wake Forest University School of Medicine, Winston-Salem |
| Pennsylvania | Allegheny General Hospital, Pittsburgh |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.